GATC Health’s AI-Driven Drug Discovery Highlighted in Becker's Healthcare Podcast

Irvine, CA – March 25, 2025 – GATC Health Corp., a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, is pleased to share its recent feature on Becker's Healthcare Podcast. In the episode titled "Revolutionizing Drug Discovery with AI: A Conversation with Dr. Rahul Gupta," Dr. Rahul Gupta, President of GATC Health, discusses the transformative potential of artificial intelligence and machine learning in revolutionizing the drug development process.

In the podcast, Dr. Gupta shares insights into how GATC Health is leveraging AI to accelerate drug discovery, reduce costs, and improve success rates. He also touches on his personal journey and experiences, including his leadership in addressing the opioid crisis.

"We are at the cusp of a new era in healthcare, where AI can significantly impact how we discover and develop life-saving treatments," said Dr. Rahul Gupta. "I am excited to share our work at GATC Health and how we are using cutting-edge technology to address some of the most pressing challenges in medicine."

Listeners can access the full podcast episode here.

About GATC Health

GATC Health Corp. is a technology company transforming drug discovery and development through its AI-driven platform and approach. The company’s validated and proprietary Multiomics Advanced Technology™ (MAT) simulates human biochemistry’s billions of interactions to rapidly create novel therapeutics, identify and confirm targets, accelerate development, and de-risk drug pipelines by predicting efficacy, safety, and off-target effects.

For more information, visit www.gatchealth.com.